Journals / Damar Cerrahi Dergisi / 2014 / Cilt: 23 - Sayı: 2

Potential Clinical Consequences of the Relationship Between Venous and Arterial Thrombosis

Venöz ve Arteriyel Trombozis Arasındaki İlişkinin Olası Klinik Sonuçları

Pages
102–106
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Statin use and anticoagulant use were found to be significant (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to explore the risk for atherothrombotic embolism (ATE) in patients with previous venous thromboembolism (VTE), as well as the risk for VTE in pa— tients with ATE, by identifying shared risk factors for both venous and arterial embolisms detected by clinical, radiological and/or laboratory findings.
📊
Key Findings & Data:It was conducted by review— ing retrospective data of 100 patients, consisting of 40 patients with ATE, 41 patients with VTE and 19 patients with ATE+VTE who were evaluated in Cardiovascular Surgery Department between Sep— tember 1, 2012 and December 1, 2012.
💡
Conclusion & Impact:Statin use and anticoagulant use were found to be significant (p
🔬Design:Review & Systematic Survey
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to explore the risk for atherothrombotic embolism (ATE) in patients with previous venous thromboembolism (VTE), as well as the risk for VTE in pa— tients with ATE, by identifying shared risk factors for both venous and arterial embolisms detected by clinical, radiological and/or laboratory findings. Material and Methods: The present study was ap— proved by Ethics Committee of Erciyes University Faculty of Medicine. It was conducted by review— ing retrospective data of 100 patients, consisting of 40 patients with ATE, 41 patients with VTE and 19 patients with ATE+VTE who were evaluated in Cardiovascular Surgery Department between Sep— tember 1, 2012 and December 1, 2012. The inclusion criteria were men and women aged between 20—80 years with atherosclerotic coronary disease, atherosclerotic peripheral artery disease, cere— brovascular disease, deep venous thrombosis, pulmonary embolism or peripheral superficial venous thrombosis. Patients With gunshot or stabbing injuries and those with blunt vascular trauma were excluded. Results: We found that age, sex, body mass index, hospitalization longer than 10 days, elevated triglycerides, chronic obstructive pulmonary disease, and hypertension were insignificant risk fac— tors for ATE and VTE (p=0.266, p=0.049, p=0.031, p=0.149, p=0.187, p=0.254, p=0.152, p=0.058, re— spectively). These risk factors increased the simultaneous occurrence risk of these two diseases. Statin use and anticoagulant use were found to be significant (p

Özet

Amaç: Bu çalışmada, klinik, radyolojik ve/veya laboratuvar olarak saptadığımız, hem venöz, hem de arteriyel trombotik olaylara eşlik eden ortak risk faktörlerini belirleyerek, daha önceden venöz tromboembolizmi (VTE) olan hastalardaki aterotrombotik embolizm (ATE) riskini ve ATE'si olan has-- talardaki VTE riskini taıtışmayı amaçladık. Gereç ve Yöntemler: Bu çalışma 01 Eylül 2012 ve 01 Ara-- lık 2012 tarihleri arasında kliniğimiztarafından değerlendirilen 40 ATE'li, 41 VTE'lj ve 19 ATE+VTE'li, toplam 100 hastanınretrospektif verileri değerlendirilerek yapılmıştır. Çalışmaya dahil edilme kriteri olarak, 20--80 yaş arası kadın ve erkek hastalar, aterosklerotik koroner arter hastalığı olanlar, aterosk-- lerotik periferik arter hastalığı olanlar, serebrovasküler hastalığı olanlar, derinven trombozu olan has-- talar, pulmoner embolisi olan hastalar ve periferik yüzeyel ven trombozu olan hastalar çalışmaya dahil edilmiştir. Ateşli silah yaralanmaları, delici kesici alet yaralanmaları, künt vasküler travmalar çalışma dışı bırakılmıştır. Bulgular: Çalışmamızda ATE ve VTE için incelenen ortak risk faktörleri olan yaş, cinsiyet, beden kitle indeksi, 10 günden uzun süreli hastanede yatış, trigliserid yüksekliği, kronik obs-- trüktif akciğer hastalığı, hipertansiyon, diabetes mellitus, istatistiki açıdan anlamlı bulunmasa da (sı-- rasıyla p=0,266, p=0,049, p=0,031, p=0,149, p=0.187, p=0,254, p=0,152, p=0,058), bu faktörler iki hastalığın beraber görülme riskini arttırma eğilimindedir. Statin kullanımı ve antikoagülan kullanımı bu açıdan istatistiki olarak anlamh bulundu (sırasıyla p

🔖

Cite This Article

TUNÇAY, A., SERHATLIOĞLU, F., ÖZMEN, R., CİHAN, M., AKÇALI, Y. F., BİÇERC, M. (2022). Potential Clinical Consequences of the Relationship Between Venous and Arterial Thrombosis. Damar Cerrahi Dergisi, Cilt: 23 - Sayı: 2, 102–106. https://ajindex.com/articles/486740

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, et al; American College of Chest Physicians. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):546S-592$. Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, et al; American College of Chest Physicians. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):776S-814S. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. EnglJ Med 2003;348(15):1435- 41. Singer GG, Brenner BM. Fluid and electrolyte disturbances. In: Fauci AS, Braunwald E, 106 Graw-Hill Companies; 2008. analysis. Eur Heart 2010;31(10)21248—56. sis. Circulation 2008;117(1):93-102. Kasper DL, et al., eds. Harrison's Principles of 9. Nieto FJ. Cardiovascular disease and risk faclnternal Medicine. 17“1 ed. New York, NY; Mc- tor epidemiology: look back at the epidemic of the 20th century. Am Public Health Squizzato A, Galli M, Romualdi E, Dentali F, 1999;89(3):292-4-
  2. Kamphuisen PW, Guasti L, et al. Statins, fi- 10. Kim RJ, Becker RC. Association between brates, and venous thromboembolism: meta- factor Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase Ageno W, Becattini C, Brighton T, Selby R, C677T mutations and events of the arterial Kamphuisen PW. Cardiovascular risk factors circulatory system: meta-analysis of puband venous thromboembolism: meta-analy- lished studies. Am Heart 2003;146(6):948- 57. Srzrrensen HT, Horvath-Puho E, Sogaard KK, 11. Deguchi H, Pecheniuk NM, Elias DJ, Averell Christensen S, Johnsen SP, Thomsen RW, et PM, Griffin JH. High-density lipoprotein defial. Arterial cardiovascular events, statins, low- ciency and dyslipoproteinemia associated with dose aspirin and subsequent risk of venous venous thrombosis in men. Circulation thromboembolism: population-based case- 2005;112(6):893-9. control study. Thromb Haemost 2009;7(4): 12 Vaya A, Mira Y, Ferrando F, Contreras M, Es521-8. Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. JAMA 1972;221(7):661-6. telles A, Espafia F, et al. Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors. Br Haematol 2002;118(1):2